Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleRE: Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval.AuthorsFreidlin, Boris; Korn, Edward L.AbstractA response from the author of the article "Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval" in the previous issue is presented.SubjectsANTINEOPLASTIC agents; DRUG therapy; DRUG approval; PHARMACODYNAMICSPublicationJNCI: Journal of the National Cancer Institute, 2016, Vol 108, Issue 3, p1ISSN0027-8874Publication typecommentaryDOI10.1093/jnci/djv430